Evidence map›Paper›PMID 18794460›Full record

ArticleArchives of dermatology2008

Variation in care for recurrent nonmelanoma skin cancer in a university-based practice and a veterans affairs clinic.

F Landon Clark, Anju Sahay, Daniel Bertenthal, Leah Maddock, Karla Lindquist, Roy Grekin, Mary-Margaret Chren

Open access · greenAbstract readComparative Study
In one paragraph

Article in Archives of dermatology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Fee comparisons of treatments for nonmelanoma skin cancer in a private practice academic setting.Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

F Landon ClarkDepartment of Dermatology, Stanford University MedicalCenter, Stanford, California, USA.
Anju Sahay
Daniel Bertenthal
Leah Maddock
Karla Lindquist
Roy Grekin
Mary-Margaret Chren
Stanford Medicine · US

Funding

Patient-Oriented Research in Skin DiseasesK24AR052667 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHREN, MARY-MARGARET · 2005 to 2014
$1.8M
Long-Term Outcomes of Nonmelanoma Skin CancerR01AR054983 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHREN, MARY-MARGARET · 2006 to 2009
$1.5M
COMPREHENSIVE OUTCOME OF NONMELANOMA SKIN CANCERK02AR002203 · NIAMS · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI CHREN, MARY-MARGARET · 2001 to 2005
$436k
NIAMS NIH HHS K02 AR002203NIAMS NIH HHS K02 AR 02203NIAMS NIH HHS K24 AR052667NIAMS NIH HHS K24- AR052667NIAMS NIH HHS R01 AR054983
6 · The paper itself

Abstract

objectiveTo learn if treatment of recurrent nonmelanoma skin cancer (NMSC) varied in different practice settings.

designProspective cohort study of consecutive patients with recurrent NMSC.

settingA university-based dermatology practice and the dermatology clinic at the affiliated Veterans Affairs Medical Center (VAMC). Conventional therapies for NMSC were available at both sites. Patients All 191 patients diagnosed as having recurrent NMSC in 1999 and 2000 were included in the study. Data were collected from medical record review and surveys mailed to patients. Main Outcome Measure Performance of Mohs micrographic surgery (Mohs).

resultsPatients at the VAMC were older, less educated, poorer, and had more comorbid illnesses, but their tumors were similar to those of patients at the university-based practice. Treatment choices differed at the 2 sites: the proportions of tumors treated in the VAMC and university sites were 60% and 14%, respectively, for excisional surgery; and 24% and 61%, respectively, for Mohs (P < .001). In multivariate analyses adjusting for patient, tumor, and physician features that may have affected treatment choice, tumors treated at the university-based site remained significantly more likely to be treated with Mohs (odds ratio, 8.68 [95% confidence interval, 3.66-20.55]; P < .001).

conclusionsSubstantial variation existed in the treatment of recurrent NMSC in different practice settings. This variation was not explained by measured clinical characteristics of the patients or the tumors.

Indexed as

Academic Medical CentersHospitals, VeteransOutpatient Clinics, HospitalProfessional PracticeAgedAged, 80 and overCohort StudiesFemaleHumansMaleMiddle AgedMohs SurgeryNeoplasm Recurrence, LocalProspective StudiesSkin Neoplasms

Identifiers

PMID18794460
PMCPMC2653265
OpenAlexW2011458009

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.